首页 › 基金 › Palogic Value Management, L.P. › HCAT

Palogic Value Management, L.P. 对 HCAT 的持仓历史

HEALTH CATALYST INC · 信息技术

Palogic Value Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 HCAT(HEALTH CATALYST INC)4,922,442 股,市值约 US$9.8M,约占其申报组合的 3.31%,在其申报持仓中市值排名第 5 位。 Palogic Value Management, L.P. 最近 7 个申报季度中有 7 个季度披露了 HCAT 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q2 2026)4.92M 股
申报持仓市值$9.80M
组合权重3.31%
首次申报Q4 2024
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Palogic Value Management, L.P. 对 HCAT 的持仓演变

Palogic Value Management, L.P. 于 Q4 2024 首次披露 HCAT 持仓:320,000 股(约 US$2.3M)。 该持仓在 Q2 2026 达到峰值 4,922,442 股,市值约 US$9.8M。 在 7 次申报中,Palogic Value Management, L.P. 6 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 4,922,442 股、市值约 US$9.8M,环比增持 2,025,842 股。。 持仓曾出现大幅变动:Q1 2025 增持约 103% (随后一个季度股价下跌 17%)、Q1 2026 增持约 128% (随后一个季度股价上涨 57%)、Q2 2026 增持约 70% (随后一个季度股价下跌 13%)。

逐季持仓明细

季度股数金额变化
Q4 2024 320.00K $2.26M 新进
Q1 2025 650.00K $2.94M 增持
Q2 2025 730.10K $2.75M 增持
Q3 2025 1.09M $3.11M 增持
Q4 2025 1.27M $3.04M 增持
Q1 2026 2.90M $3.68M 增持
Q2 2026 4.92M $9.80M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 HCAT 与 13F 数据

HCAT(HEALTH CATALYST INC)属于信息技术行业。我们追踪的基金中还有 7 只申报持有 HCAT,申报仓位最大的包括:First Light Asset Management, LLC (US$25.5M), CDC Financial, Inc. (US$14.1M), Nepsis Inc. (US$5.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 HCAT 的基金

查看 HCAT 的全部基金持有人 →

常见问题

How long has Palogic Value Management, L.P. held HCAT?

Palogic Value Management, L.P. has disclosed HCAT holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Palogic Value Management, L.P.'s current position in HCAT?

As of Q2 2026, Palogic Value Management, L.P. holds 4.92M shares of HCAT (HEALTH CATALYST INC), valued at $9.80M, representing 3.31% of its reported portfolio and ranking #5.

Has Palogic Value Management, L.P. been buying or selling HCAT?

In the latest 13F filing (Q2 2026), Palogic Value Management, L.P. increased its position in HCAT. The position peaked in Q2 2026 at 4.92M shares.

Which other funds hold HCAT?

Other major institutional holders of HCAT include First Light Asset Management, LLC, CDC Financial, Inc., Nepsis Inc., among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.